Abstract
Although depression is known to be an independent risk factor for cardiovascular disorders, the mechanisms behind this connection are not well understood. However, the reduction in the number of endothelial progenitor cells (EPCs) in patients with cardiovascular risk factors has led us to hypothesize that depression influences the number of EPCs. EPCs labeled with CD34, CD133 and vascular endothelial growth factor receptor-2 (VEGFR2) antibodies were counted by flow cytometry in the peripheral blood (PB) of 33 patients with a current episode of major depression and of 16 control subjects. Mature (CD34+/VEGFR2+) and immature (CD133+/VEGFR2+) EPC counts were decreased in patients (vs controls; P<0.01 for both comparisons), and there was a significant inverse relationship between EPC levels and the severity of depressive symptoms (P<0.01 for both EPC phenotypes). Additionally, we assayed the plasma levels of VEGF, C-reactive protein (CRP) and tumor necrosis factor (TNF)-α and observed significantly elevated TNF-α concentrations in patients (vs controls; P<0.05) and, moreover, a significant inverse correlation between TNF-α and EPC levels (P<0.05). Moreover, by means of a quantitative RT-PCR approach, we measured CD34, CD133 and VEGFR2 mRNA levels of PB samples and found a net trend toward a decrease in all the investigated EPC-specific mRNA levels in patients as compared with controls. However, statistical significance was reached only for VEGFR2 and CD133 levels (P<0.01 for both markers). This is the first paper that demonstrates evidence of decreased numbers of circulating EPCs in patients with a current episode of major depression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rihmer Z, Angst J . Mood disorders: epidemiology. In: Sadock BJ, Sadock VA (eds). Kaplan & Sadock's Comprehensive Textbook of Psychiatry, 8th edn. Lippincott Williams & Wilkins: Philadelphia, 2005, pp 1576–1582.
Weeke A, Juel K, Vaeth M . Cardiovascular death and manic-depressive psychosis. J Affect Disord 1987; 13: 287–292.
Everson-Rose SA, Lewis TT . Psychosocial factors and cardiovascular diseases. Annu Rev Public Health 2005; 26: 469–500.
Baune BT, Adrian I, Arolt V, Berger K . Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom 2006; 75: 319–326.
Rihmer Z . Suicide risk in mood disorders. Curr Opin Psychiatry 2007; 20: 17–22.
Glassman AH . Does treating post-myocardial infarction depression reduce medical mortality? Arch Gen Psychiatry 2005; 62: 711–712.
Kamphuis MH, Kalmijn S, Tijhuis MA, Geerlings MI, Giampaoli S, Nissinen A et al. Depressive symptoms as risk factor of cardiovascular mortality in older European men: the Finland, Italy and Netherlands Elderly (FINE) study. Eur J Cardiovasc Prev Rehabil 2006; 13: 199–206.
Rugulies R . Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med 2002; 23: 51–61.
Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004; 66: 305–315.
Williams LS . Depression and stroke: cause or consequence? Semin Neurol 2005; 25: 396–409.
Larson SL, Owens PL, Ford D, Eaton W . Depressive disorder, dysthymia, and risk of stroke: thirteen-year follow-up from the Baltimore epidemiologic catchment area study. Stroke 2001; 32: 1979–1983.
Salaycik KJ, Kelly-Hayes M, Beiser A, Nguyen AH, Brady S, Kase CS et al. Depressive symptoms and risk of stroke: the Framingham Study. Stroke 2007; 38: 16–21.
Holtzheimer III PE, Nemeroff CB . Future prospects in depression research. Dialogues Clin Neurosci 2006; 8: 175–189.
Khakoo AY, Finkel T . Endothelial progenitor cells. Annu Rev Med 2005; 56: 79–101.
Lin EH, Hassan M, Li Y, Zhao H, Nooka A, Sorenson E et al. Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence. Cancer 2007; 110: 534–542.
Mehra N, Penning M, Maas J, Beerepoot LV, van Daal N, van Gils CH et al. Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases. Clin Cancer Res 2006; 12: 4859–4866.
Rabascio C, Muratori E, Mancuso P, Calleri A, Raia V, Foutz T et al. Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells. Cancer Res 2004; 64: 4373–4377.
Dome B, Hendrix MJ, Paku S, Tovari J, Timar J . Alternative vascularization mechanisms in cancer: pathology and therapeutic implications. Am J Pathol 2007; 170: 1–15.
Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964–967.
Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004; 53: 195–199.
Chen JZ, Zhang FR, Tao QM, Wang XX, Zhu JH, Zhu JH . Number and activity of endothelial progenitor cells from peripheral blood in patients with hypercholesterolaemia. Clin Sci (Lond) 2004; 107: 273–280.
Imanishi T, Moriwaki C, Hano T, Nishio I . Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831–1837.
Herbrig K, Pistrosch F, Foerster S, Gross P . Endothelial progenitor cells in chronic renal insufficiency. Kidney Blood Press Res 2006; 29: 24–31.
Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005; 111: 204–211.
Kondo T, Hayashi M, Takeshita K, Numaguchi Y, Kobayashi K, Iino S et al. Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442–1447.
Rehman J, Li J, Parvathaneni L, Karlsson G, Panchal VR, Temm CJ et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 2004; 43: 2314–2318.
Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002; 105: 3017–3024.
Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D . Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 2005; 45: 526–529.
Gensch C, Clever YP, Werner C, Hanhoun M, Bohm M, Laufs U . The PPAR-gamma agonist pioglitazone increases neoangiogenesis and prevents apoptosis of endothelial progenitor cells. Atherosclerosis 2007; 192: 67–74.
Reiche EM, Nunes SO, Morimoto HK . Stress, depression, the immune system, and cancer. Lancet Oncol 2004; 5: 617–625.
Raison CL, Capuron L, Miller AH . Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24–31.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC, 1994.
Kopp MS, Skrabski A, Szedmak S . Socioeconomic factors, severity of depressive symptomatology, and sickness absence rate in the Hungarian population. J Psychosom Res 1995; 39: 1019–1029.
National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143–3421.
Sussman LK, Upalakalin JN, Roberts MJ, Kocher O, Benjamin LE . Blood markers for vasculogenesis increase with tumor progression in patients with breast carcinoma. Cancer Biol Ther 2003; 2: 255–256.
Liew A, Barry F, O'Brien T . Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 2006; 28: 261–270.
Gehling UM, Ergun S, Schumacher U, Wagener C, Pantel K, Otte M et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 2000; 95: 3106–3112.
Hristov M, Erl W, Weber PC . Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003; 23: 1185–1189.
Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST et al. Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology 2006; 44: 836–843.
Michaud SE, Dussault S, Haddad P, Groleau J, Rivard A . Circulating endothelial progenitor cells from healthy smokers exhibit impaired functional activities. Atherosclerosis 2006; 187: 423–432.
Frasure-Smith N, Lesperance F . Recent evidence linking coronary heart disease and depression. Can J Psychiatry 2006; 51: 730–737.
Johnson AK, Grippo AJ . Sadness and broken hearts: neurohumoral mechanisms and co-morbidity of ischemic heart disease and psychological depression. J Physiol Pharmacol 2006; 57 (Suppl 11): 5–29.
Pratt LA, Ford DE, Crum RM, Armenian HK, Gallo JJ, Eaton WW . Depression, psychotropic medication, and risk of myocardial infarction. Prospective data from the Baltimore ECA follow-up. Circulation 1996; 94: 3123–3129.
Carney RM, Rich MW, Freedland KE, Saini J, teVelde A, Simeone C et al. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom Med 1988; 50: 627–633.
Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058–2067.
Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C et al. p38 Mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005; 111: 1184–1191.
Ablin JN, Boguslavski V, Aloush V, Elkayam O, Paran D, Caspi D et al. Effect of anti-TNFalpha treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci 2006; 79: 2364–2369.
O'Brien SM, Scott LV, Dinan TG . Antidepressant therapy and C-reactive protein levels. Br J Psychiatry 2006; 188: 449–452.
Lanquillon S, Krieg JC, Bening-Abu-Shach U, Vedder H . Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370–379.
Anderson RJ, Freedland KE, Clouse RE, Lustman PJ . The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001; 24: 1069–1078.
Tossani E, Cassano P, Fava M . Depression and renal disease. Semin Dial 2005; 18: 73–81.
Paperwalla KN, Levin TT, Weiner J, Saravay SM . Smoking and depression. Med Clin North Am 2004; 88: 1483–1494.
Sheehy C, Murphy E, Barry M . Depression in rheumatoid arthritis—underscoring the problem. Rheumatology (Oxford) 2006; 45: 1325–1327.
Acknowledgements
BD is a recipient of the Bolyai Janos Scholarship of the Hungarian Academy of Sciences. This study was further supported by National Science Foundation-OTKA-F68916 (BD); ‘Oveges Jozsef Program’ of the Hungarian Agency for Research Fund Management and Research Exploitation (BD and J Tovari). GVOP-0040-2004, KFIIF-00063/2005, Hungarian Ministry of Health ETT-410/2006 (BD); National Science Foundation-OTKA-TS49887, Hungarian Ministry of Health-ETT-383/2006 (SP); National Science Foundation-OTKA-D048519, National Science Foundation-OTKA-F046501 (J Tovari); Hungarian Ministry of Education, NKFP1a-0024-05 (J Timar).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dome, P., Teleki, Z., Rihmer, Z. et al. Circulating endothelial progenitor cells and depression: a possible novel link between heart and soul. Mol Psychiatry 14, 523–531 (2009). https://doi.org/10.1038/sj.mp.4002138
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4002138
Keywords
This article is cited by
-
Neurophysiological stratification of major depressive disorder by distinct trajectories
Nature Mental Health (2023)
-
Associations between increased circulating endothelial progenitor cell levels and anxiety/depressive severity, cognitive deficit and function disability among patients with major depressive disorder
Scientific Reports (2021)
-
Pentoxifylline ameliorates chronic stress/high-fat diet-induced vascular wall disease: the role of circulating endothelial progenitor cells
Naunyn-Schmiedeberg's Archives of Pharmacology (2019)
-
Vascular endothelial growth factor plasma levels in depression and following electroconvulsive therapy
European Archives of Psychiatry and Clinical Neuroscience (2018)
-
Depression pathogenesis and treatment: what can we learn from blood mRNA expression?
BMC Medicine (2013)